All 1 tracked stories fall under one category: funding. Form Bio is most often covered alongside Astromech, which appears in 1 of these 1 story. We currently track 1 Startup story that mention Form Bio, all published on July 21, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Form Bio
All 1 tracked stories fall under one category: funding. Form Bio is most often covered alongside Astromech, which appears in 1 of these 1 story. We currently track 1 Startup story that mention Form Bio, all published on July 21, 2026. Each carries 2 original sources on average.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 8 Startup stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Form Bio. Shared-story counts are live from our verified record — not editorial picks.
Venture capital’s most audacious bet, Colossal Biosciences, is seeking a valuation of $20–$30 billion — a nearly 3x jump — as it generates revenue, spins out high-value startups, and turns its de-extinction mission into a startup factory with government clients and AI-driven assets.
Form Bio is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.